Table 1.
No. | Gender | Age (yr) | Reason of LAPEG | BMI before the procedure/albumin concentration (g/dL) | BMI after 12 mo follow up | Time from insertion of the gastroscope to the peg placement (total operation length)/min | Time form insertion laparoscope to removal of the laparoscope/min |
1 | F | 7 | Tay-Sachs disease | 11.9/2.9 | 14.5 | 22 | 16 |
2 | M | 5 | drug-resistant epilepsy | 13.9/3.9 | 15.2 | 17 | 13 |
3 | M | 15 | cerebral palsy | 13.2/4.5 | 15.2 | 15 | 9 |
4 | F | 3 | Patau syndrome | 13.8/5.1 | 16.0 | 21 | 12 |
5 | M | 17 | cerebral palsy | 12.6/3.3 | 18.4 | 24 | 14 |
6 | M | 11 | cerebral palsy | 13.2/3.7 | 17.1 | 22 | 9 |
7 | F | 22 | Wilson’s disease | 12.0/28 | 13.5 | 21 | 17 |
8 | F | 31.5 | Gaucher’s disease | 14.5/29.5 | 14.5 | 18 | 12 |
9 | M | 26.2 | cerebral palsy | 15.5/27.0 | 15.2 | 16 | 8 |
10 | F | 33.2 | SLA | 14.0/25.0 | 17.0 | 12 | 11 |
11 | F | 34 | SLA | 11.0/2.3 | 14.5 | 14 | 11 |
12 | F | 24.7 | cerebral palsy | 11.5/2.9 | 15.0 | 13 | 7 |
BMI: Body mass index; LAPEG: LA-percutaneous endoscopic gastrostomy; SLA: Amyothropic later sclerosis; M: Male; F: Female.